[{"_1":2,"_100":-5,"_101":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,76,88],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},"mediaId",6373916,"mediaKeyId","2145249-11835ed26893285d5d4f8096b2e15633","parentId",2145249,"title","Committee backs resolution asking PEHP to pass pharmacy rebates through at point of sale","audioSeconds",1057,"startMs",1974000,"endMs",3031000,"viewUrl","/Search/View?dp=1&key=2145249-11835ed26893285d5d4f8096b2e15633&start=1974&end=3031","thumbnailUrl","https://assets.pipeline.soar.com/2145249-11835ed26893285d5d4f8096b2e15633/thumbnail_1974000.jpg","articleUrl","/articles/6373916/Utah/Committee-backs-resolution-asking-PEHP-to-pass-pharmacy-rebates-through-at-point-of-sale","mediaUrl","https://secure.pipeline.soar.com/6373916-9fee2d76117f2f1e0946f2f2b88b0be7/orig.mp4?Expires=1770455448&Signature=DDXef4Ts5UlDMqQ5r9XhXhQz9blmHOpz4agAUTAPkGvYojjvDekLrH1CkTEOcZRaYgOczxBMyDqkv9AHutoMBol-6YzP6BAteIL9szf1yhYKLi53yVdLmuym9J-w1urVhVq~v8Zoyj0IL99MqwULSN0y2AiwTiZezffUw91Z1~HoBT8bJwV5to1XhblSFORDatlBBMBVal2t8Sdf1neobbCbypnUvy0yLyE-IBKaS8-uxxlcoMQDm~HWpr-gJyRuP49bOffv2d0mw43~3YhE3PCQvjluLKttJ90oqMJUFDgOIq-T21e795ZSZAqK5~7Ojem4cnernD99MZ7HUiWmNQ__&Key-Pair-Id=KUT5TJCACFTXG","author","Utah State Legislature","date","2025-01-23T00:00:00Z","article","Representative Thurston presented HCR 2, a concurrent resolution directing PEHP to pass pharmacy manufacturer rebates through to patients at the point of sale. He and PEHP representative Chet Loftus said the proposal would make the patient’s out‑of‑pocket price closer to the drug’s net cost by applying estimated rebates when the prescription is dispensed.

\"Rather than patients having to pay an extra amount for that back end piece to happen, they just pay the regular price of a drug,\" Thurston told the committee. Chet Loftus of PEHP described prior use of the practice for insulin and EpiPens and said the agency has operational experience, though implementing the change broadly requires technical work with PBMs and pharmacies.

Committee members asked about the fiscal note and how the change would be funded. Thurston and PEHP staff said the change is self‑funding within each risk pool: rebates already collected on behalf of members would instead be distributed at dispensing, and PEHP estimated the per‑member per‑month cost to spread across the membership at about $2.84. Representative Eliason pressed on why the fiscal note showed zero state general fund impact; PEHP replied that the change reallocates existing rebate dollars within the group rather than requiring a new appropriation.

The committee adopted Amendment 1 (a technical update to the cost estimate) and then passed HCR 2 with a favorable recommendation by voice vote; the chair recorded the motion as unanimous. Committee discussion cited prior PEHP programs that reduced insulin costs at point of sale and estimated the total state impact at roughly $2 million under the assumptions presented.

The resolution directs PEHP to implement the pass‑through approach and asks the agency to report implementation details to the Legislature; no binding appropriation clause was attached to the resolution as presented.","mediaType","Video","parentTitle","House Health and Human Services Committee - January 23, 2025","oneSentenceSummary","Representative Thurston told the Health and Human Services Committee HCR 2 would direct PEHP to pass manufacturer rebates through to patients at the pharmacy, reducing the patient’s point-of-sale price.","taxTitle","2025 Utah Legislature, Utah Legislature, Utah Legislative Branch, Utah","taxId",78171,"location","Utah","headline","","shortSummary",{"_33":77,"_35":36,"_37":38,"_39":78,"_41":79,"_43":80,"_45":81,"_47":82,"_49":83,"_51":84,"_53":85,"_55":56,"_57":58,"_59":86,"_61":62,"_63":64,"_65":87,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6373921,"Committee pauses pharmacy-accessibility bill after debate over costs, implementation",1655,305000,1960000,"/Search/View?dp=1&key=2145249-11835ed26893285d5d4f8096b2e15633&start=305&end=1960","https://assets.pipeline.soar.com/2145249-11835ed26893285d5d4f8096b2e15633/thumbnail_305000.jpg","/articles/6373921/Utah/Committee-pauses-pharmacy-accessibility-bill-after-debate-over-costs-implementation","https://secure.pipeline.soar.com/6373921-ee0dfb9771852a7081465785c97fee50/orig.mp4?Expires=1770455448&Signature=Q3vkmVCrx-QBtx8V8yW63QsxOtVh~XUucFPI1MOON84yLY3eNYq24udzk39F5vFRWAx2of-nDerkgLK9N-7Bb9g3M6H13qlgiMJKvfQ03-yMew0t-4jPvEwLutqd6cEJ9MksZ8nQ7FbKbTNUgwvAq~SNzfJhMBEwVXYC9KKdSqN4PRJT6tvzEGqGlfDw6gggF5V74vhf7h8oZmZNcqwZ~TMjKIOpoBfiHo783ML3DVi83dlzJ98xYg5FgRsG9GPTNsr4o0~1yWLxA3jBQwPYVEbs~C8LlXnQTFQmrIGEgcPINx6X4rkHhf7Yt88ja0Ia0omGNG~rJiOlSmwXuhferw__&Key-Pair-Id=KUT5TJCACFTXG","Representative Jen Daley Provo presented HB 123, the pharmacy accessibility amendments, telling the House Health and Human Services Committee the bill’s first substitute would require pharmacies to use \"best efforts\" to provide prescription information in at least one accessible format — large print, braille, or an auditory option — and that the substitute delayed implementation to ease cost and supply concerns.

The bill aims to address cases in which visually impaired patients have received prescription labels they cannot read. \"So many other blind and low vision individuals across the state, 45,000 individuals in Utah, identify as having a significant vision loss,\" Everett Bacon, president of the National Federation of the Blind of Utah, told the committee. He described instances in which people were denied accessible prescription options and urged lawmakers to change pharmacy practices.

Supporters and witnesses emphasized different solutions. Bacon described an auditory chip and a QR-like device used by some pharmacies that allows a smartphone app or a handheld reader to speak label contents aloud. Mary Anne Martin, CEO of the Utah Academy of Family Physicians, said an RFID-style chip can cost only “a buck or two” and allows patients to remain independent. Rachel Craig of the Association for Utah Community Health said most community health center pharmacies already provide some accessibility and that centers could comply with a delayed implementation schedule.

Pharmacy and retail representatives raised implementation concerns. Adam Jones of the Utah Pharmacy Association warned of low margins in pharmacy and noted national pharmacy closures, saying smaller, independent pharmacies may struggle to incur extra costs. Dave Davis of the Utah Retail Merchants Association suggested the State Board of Pharmacy should weigh in on technical details, and he asked how the bill would define someone who \"identifies as visually impaired\" and whether language barriers would trigger obligations under the bill. The association representative also noted that current Utah statute already requires pharmacies to offer an opportunity to consult with a pharmacist.

Committee members pressed about legal and enforcement consequences and what counts as compliance. Representative Ray Ward asked whether printing in large type would meet the patient’s preference; the sponsor replied the substitute requires pharmacies to use their \"best efforts\" to provide at least one of the listed formats and recognized ambiguity over how preferences would be interpreted in practice. The sponsor also said the substitute includes a delayed effective date to accommodate ordering and budgeting for equipment.

After discussion, the committee adopted the first substitute for HB 123 by voice vote. A subsequent motion to hold the bill passed, removing it from immediate consideration so the sponsor and stakeholders can continue negotiations. No civil penalties or enforcement mechanism were specified in the substitute as presented to the committee.

The committee’s action pauses HB 123 while sponsors and pharmacy stakeholders discuss definitions, implementation timelines and the role, if any, of the State Board of Pharmacy in advising technical standards.","Representative Jen Daley Provo presented HB 123, the pharmacy accessibility amendments, telling the House Health and Human Services Committee the bill’s first substitute would require pharmacies to use \"best efforts\" to provide prescription information in at least one accessible format — large print, braille, or an auditory option.",{"_33":89,"_35":36,"_37":38,"_39":90,"_41":91,"_43":92,"_45":93,"_47":94,"_49":95,"_51":96,"_53":97,"_55":56,"_57":58,"_59":98,"_61":62,"_63":64,"_65":99,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6373911,"Committee clears bill syncing Utah law with FDA mammography notice language",245,3091000,3336000,"/Search/View?dp=1&key=2145249-11835ed26893285d5d4f8096b2e15633&start=3091&end=3336","https://assets.pipeline.soar.com/2145249-11835ed26893285d5d4f8096b2e15633/thumbnail_3091000.jpg","/articles/6373911/Utah/Committee-clears-bill-syncing-Utah-law-with-FDA-mammography-notice-language","https://secure.pipeline.soar.com/6373911-2a8728d73f6e4785c735b21e528ab687/orig.mp4?Expires=1770455448&Signature=PJ52sClZmdPZdb4KfDNbLCWdUcAwHw~hsnRiocCd~6OC4qGMuHst~kJFq3aHc3KlK4E7X6-3lycGmRkrunu2eI~cL6xYoO4NIlJSmtsmLg3bvAJcH9qHdRh9nfrtIuCZHQPKpy3E4BdbR-T7qKcROHZ4F00-sSojmuNRV18fxJlZ5GTBN9O1WS6am~vVv0eSDzC~ult7d7j3my6fzl2T2o6qrVaDT4rPhfBKGx3Y98C9QTMtSRQg-BGq5qQFfH8rzGhGR0FdMp-vDKCIluKcEeWNl9MqkI0NGmXgd-4aWYNCIbDL5vOr5wyxju-0AAPyj1cQJ1GbeuivyUuD0i2svg__&Key-Pair-Id=KUT5TJCACFTXG","Representative Hall urged approval of HB 146, which updates Utah code to remove the state’s existing dense-breast notification language and defer to the Food and Drug Administration’s federally required mammography notification.

\"For years, Utah has required mammography providers to share a notification with patients who have dense breast tissue,\" Hall said. He told the committee the federal FDA language, adopted in September, is broader than the state statute because it requires a notification whether or not a patient has dense tissue; the bill removes the duplicative state language so providers are not required to use two different statements.

Hall said the Department of Health and Human Services reviewed options and that providers are already using the FDA statement; he also noted the statutory language could be reintroduced later if federal rules change. There was no public testimony recorded and no amendments offered. Representative Tyler Clancy moved to recommend the bill favorably; the committee approved the motion by voice vote.

Sponsor Hall said he would pay continued attention to the issue; he noted a personal stake, saying, \"I lost my mom to breast cancer,\" while urging vigilance about how federal rules evolve. The bill now moves from committee with a favorable recommendation.","House bill 146 would remove an older Utah statutory notice about dense breast tissue and rely on the FDA's matched, federal mammography-notification language. Sponsor Representative Hall said the federal requirement uses broader wording and that providers already follow the FDA language; the committee recommended the bill favorably with no public","actionData","errors"]

Article not found

Committee backs resolution asking PEHP to pass pharmacy rebates through at point of sale

Committee pauses pharmacy-accessibility bill after debate over costs, implementation

Committee clears bill syncing Utah law with FDA mammography notice language